Trial intelligence / Profile preview

Ferric Carboxymaltose in Pre-dialysis CKD Anemia

NCT02232906Phase 4Completed

Sponsor
Hospital Alemán
Start
Mar 2011
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Hospital Alemán. Started Mar 2011; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02232906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02232906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call